This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rosenfeld, M.A. et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143–155 (1992).
Crystal, R.G. et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet. 8, 42–51 (1994).
Crystal, R.G. Protocol for gene therapy of the respiratory manifestations of cystic fibrosis using a replication deficient recombinant adenovirus to transfer the normal cystic fibrosis transmembrane conductance regulator cDNA to the airway epithelium. Fed. Register 58, 21737–21738 (1992).
Brody, S.L., Metzger, M., Danel, C., Rosenfeld, M. & Crystal, R.G. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA. Hum. Gene Ther. 5, 821–836 (1994).
Zabner, J. et al. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75, 207–216 (1993).
Wilson, J.M. Gene therapy of cystic fibrosis lung disease using El deleted adenovirus: a phase 1 trial. Fed. Register 58, 47906 (1993).
Boucher, R.C. & Knowles, M.R. Gene therapy for cystic fibrosis using El deleted adenovirus: a phase 1 trial in the nasal cavity. Fed. Register 58, 53814 (1993).
Wilmott, R.W., Whitsett, J. & Trapnell, B. A phase 1 study of gene therapy of cystic fibrosis utilizing a replication deficient recombinant adenovirus vector to deliver the human cystic fibrosis transmembrane conductance regulator cDNA to the airways. Fed. Register 58, 21739 (1993).
Van Snick, J., Interleukin-6: An overview. Annu. Rev. Immun. 8, 253–278 (1990).
Weber, J. et al. Phase 1 trial of subcutaneous interleukin-6 in patients with advanced malignancies. J. clin. Oncol. 11, 499–506 (1993).
McElvaney, N.G. et al. Modulation of airway inflammation in cystic fibrosis: in vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. J. clin. Invest. 90, 1296–1301 (1992).
Melani, C. et al. Interleukin-6 expression in human neutrophil and eosinophil periphera blood granulocytes. Blood 81, 2744–2749 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McElvaney, N., Crystal, R. IL-6 release and airway administration of human CFTR cDNA adenovirus vector. Nat Med 1, 182–184 (1995). https://doi.org/10.1038/nm0395-182b
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0395-182b